TPD & Induced Proximity Summit Leaderboard
  • Sunday, July 5, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

Oligonucleotides Analytical Development & CMC Summit Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 342

Author

Pharma Journalist 8916 posts 0 comments

Moderna Announces Submission of Initial Data to FDA for Its COVID-19 Vaccine Booster

Sep 1, 2021
Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines announced it has initiated its submission to the U.S. Food and Drug Administration (FDA)…
Read More...

World-first agreement between Novartis and the NHS enables broad and rapid access to first-in-class…

Sep 1, 2021
Novartis has reached a commercial agreement with the NHS in England as part of a collaboration to pioneer a first-of-its-kind population health management approach to address elevated…
Read More...

Janssen Announces U.S. FDA Approval of INVEGA HAFYERA

Sep 1, 2021
The Janssen Pharmaceutical Companies of Johnson & Johnson announced the U.S. Food and Drug Administration (FDA) has approved long-acting atypical antipsychotic INVEGA HAFYERA…
Read More...

Innovent and GenFleet Announce Exclusive Global License Agreement for GFH925 (KRAS G12C Inhibitor)

Sep 1, 2021
Innovent Biologics, Inc. a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune…
Read More...

Moderna Announces Submission of Initial Data to U.S. FDA for Its COVID-19 Vaccine Booster

Sep 1, 2021
Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines announced it has initiated its submission to the U.S. Food and Drug Administration (FDA)…
Read More...

On-body biosensors: A human factors development approach

Sep 1, 2021
SMi Reports: Exploring therapeutic applications of connected on-body devices at Medical Wearables for Biosensors conference Biosensors and wearable devices are gaining substantial…
Read More...

Digital applications for on-body devices discussed at Wearable Injectors and Connected Devices…

Sep 1, 2021
SMi Group reports: The latest innovations in digital health and on-body drug delivery for the pharmaceutical industry The upcoming conference in October will consider key…
Read More...

Teva and MedinCell Announce FDA Acceptance of New Drug Application for TV-46000/mdc-IRM as a…

Aug 31, 2021
Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd., and MedinCell announced that the New Drug Application (NDA) for TV-46000/mdc-IRM (risperidone…
Read More...

Senhwa’s Silmitasertib, COVID-19 Drug Candidate, Receives Positive Interim Review from Data…

Aug 31, 2021
Senhwa Biosciences, Inc. a drug development company focused on first-in-class therapeutics for oncology, rare diseases, and novel coronaviruses, announced that its oral new drug,…
Read More...

Data from Multiple Studies Show Positive Outcomes with Gala Therapeutics’ RheOx System for…

Aug 31, 2021
Gala Therapeutics, Inc. (Gala), a developer of medical devices to treat pulmonary disease, announced new data from multiple clinical studies that demonstrate improvements in chronic…
Read More...
Prev Next
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
2nd Operationalize: Expanded Access Programs Summit West
Neuropsychiatric Drug Development Summit
International Neoantigen Summit
Lab Ops & Facility Management for Biopharma West Summit
10th IPF Summit
Medical Device Software Development Summit
Liquid Biopsy for Precision Oncology Summit East Coast
ADC Linker & Conjugation Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
In Vivo Cell Engineering & Gene Editing Summit
Obesity & Weight Loss Drug Development Summit
T-Cell Engager Therapeutics Summit
mRNA-Based Therapeutics Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • Arcturus Partners With Thermo Fisher on Cystic Fibrosis mRNA Therapy
  • Lonza Secures Nona’s BBB Technology for CNS Drug Development
  • Ipsen Acquires Memo Therapeutics to Advance BK Virus Treatment
  • AlzeCure Licenses Alzheimer’s Drug Candidate ACD856 in $2.2B Deal
  • Inocras, AimedBio Partner to Advance ADC Precision Oncology Development

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Advancing Respiratory Medicine Following ATS – What Now?

World ADC San Diego Unveils Preliminary Agenda for 17th…

Regeneron Goes All In on Radiopharma with $2.1B Telix Deal…

IQ MPS Leaders to Share Industry Progress on Advancing In…

4th ADC Linker & Conjugation Summit Announces 2026…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.